These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 169108)

  • 1. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
    Traub WH; Kleber I
    Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of polymyxin B nonapeptide to augment bactericidal activities of novobiocin, rifampin, and of defibrinated human blood against Serratia marcescens.
    Traub WH; Kohl KH; Spohr M; Bauer D
    Chemotherapy; 1988; 34(3):195-201. PubMed ID: 2843325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable neutralization of several nonspecific antibacterial systems in fresh, defibrinated human blood by sodium polyanetholsulfonate and sodium amylosulfate.
    Traub WH; Fukushima PI
    J Clin Microbiol; 1979 Jul; 10(1):27-31. PubMed ID: 227919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum.
    Traub WH; Acker G; Kleber I
    Chemotherapy; 1976; 22(2):104-13. PubMed ID: 176013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. II. Aminoglycosides: amikacin, gentamicin, and netilmicin.
    Traub WH
    Chemotherapy; 1982; 28(6):434-43. PubMed ID: 6761079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.
    Traub WH
    Chemotherapy; 1982; 28(5):363-8. PubMed ID: 6291867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro additive effect of polymxin B and rifampin against Serratia marcesen.
    Traub WH; Kleber I
    Antimicrob Agents Chemother; 1975 Jun; 7(6):874-6. PubMed ID: 168807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin.
    Traub WH
    Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.
    Traub WH; Kleber I
    Infect Immun; 1976 May; 13(5):1343-6. PubMed ID: 818023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined serum bactericidal and phagocytic activities of defibrinated human blood against Serratia marcescens. Use of phenylbutazone to selectively block phagocytic killing activity and of Group A (phage tail) bacteriocins to kill extraphagocytic bacteria.
    Traub WH
    Chemotherapy; 1982; 28(5):355-62. PubMed ID: 6754279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.
    Traub WH; Kleber I
    J Clin Microbiol; 1977 Mar; 5(3):278-84. PubMed ID: 192756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of alaphosphin (Ro 03-7008) against Serratia marcescens.
    Traub WH
    Chemotherapy; 1980; 26(2):103-10. PubMed ID: 6988181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of saline on the releasability of alkaline phosphatase from cells of Serratia marcescens.
    Kranz DM; Tsang JC
    Microbios; 1976; 15(61-62):165-75. PubMed ID: 189160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.